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LIVER REPLACEMENT with a homograft was first 
attempted in a human on 1 March 1963 (29). 
Between then and Thanksgiving Day 1974,92 more 
patients were similarly treated at our center. In this 
review, it will be emphasized that 27 of the 93 
recipients achieved survival of at least one year 
after transplantation with a maximum of six years 
and that many of these patients have been able to 
return to a full and useful life. At the same time, 
attention will be focused upon the causes for the 
heavy mortality that has retarded the acceptance of 
this new procedure and upon means by which the 
record might be improved. 
METHODS 
Material 
Pediatric patienis. Fifty-six of the 93 recipients were 
18 years of age or younger at the time of opera-
tion (Table I). Forty of these 56 pediatric recipients 
had biliary atresia. In the 36 youngest of the 40 
patients with atresia, the mean age at operation was 
31.3±15.7 (S.D.) months, range 3 to 67. The four 
oldest children in the atresia group were seven, 11, 
11 and 15 years of age. Because of their long sur-
vival, they were thought, on clinical grounds, to 
have intrahepatic biliary atresia, and this diagnosis 
was compatible with the histopathologic findings of 
micronodular biliary cirrhosis in their native livers. 
Two of these latter four livers contained incidental 
liver cell carcinomas. Only one such malignant con-
dition was found in the diseased livers of the other 
36 patients with extrahepatic biliary atresia in 
whom transplantations were carried out at a 
younger age. 
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The 16 pediatric recipients with diagnoses other 
than biliary atresia (Table I) had a mean age of 
12.9±4.6 (S.D.) years, range 1 to 18. Nine had 
some variant of chronic aggressive hepatitis without 
HB.AG antigenemia. Three had hepatomas which 
could not be removed with conventional partial 
hepatectomy. Two had Wilson's disease. There was 
one example each of congenital biliary cirrhosis and 
cirrhosis associated with alpha-I-antitrypsin defi-
ciency of the homozygous PiZZ phenotype. 
Adult patients. The 37 adult patients treated dur-
ing the same time averaged 39.0 ± 11.1 (S.D.) 
years, range 21 to 68. Their most frequent diagnoses 
were primary hepatic malignant tumor, chronic 
aggressive hepatitis and alcoholic cirrhosis (Table 
II). All of the patients with non-neoplastic disease 
were profoundly ill before they were considered for 
transplantation. Five had a diagnosis of the 
hepatorenal syndrome; several were unconscious; 
almost all were wasted from the chronic disease. 
For specific patients of either the adult or pedia-
tric subgroup, orthotopic transplant or OT code 
numbers have been given, so that the reader may 
follow given recipients through different publica-
tions from our center. This method of patient 
identification has been used for most of our past 
publications, beginning with a major review of our 
experience in 1969 (31). 
Management 
The operative care and postoperative care of 
patients with liver transplantation have been 
described before (25, 31), but some details deserve 
emphasis. Since 1968 when the concept of brain 
death became widely accepted in the United 
States, cadavers usually have not been considered 
for liver donation unless there is still effective cir-
culation and unless aortography can be performed 
to delineate the hepatic arterial supply in advance. 
Complicated preservation devices are no longer 
used. The livers of infants and children are usually 
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TABLE I.-PEDIATRIC PATIENTS 
Follow-up period 
No. of Survival Alive* present survivors, OT Nos. 
Diagnosis examples > 1 yr. now mos. oj survivors 
Congenital biliary atresia ....... . 40 11 (27.5) 7 13, 15,26,34, 91,89,73,64, 
Chronic aggressive hepatitis ....................... . 
Hepatoma, liver cell carcinoma ..................... . 
46,53,71 53,46,33 
9 3 (33) 2 13,22 92,77 
3 2 (67) a 
VV'ilson's disease ......................................... . 2 2 (100) 1 57 42 
Congeni tal biliary cirrhosis t . . ................ . 1 1 (100) 1 43 56 
Alpha-1-antitrypsin deficiency ............................ . 1 1 (100) 1 25 74 
Total.. ..... ................ . ................. . 56 20 12 13-71 
Figures in parentheses indicate percentages. 
None of the 56 pediatric patients were llB.:;Ag- positive preoperati\-ely. 
*The eight latc deaths were after 12Y2, 13, 13Y2, 14,26,30,41 and 72 months; causes given in text and Table IV. 
tAssociated with congenital deafness. 
TABLE n.-ADULT PATIENTS 
Diagnosis 
Malignant tumor* .............. . 
Chronic aggressive hepatitis ...... . 
Alcoholic cirrhosis.. . .......... . 
Primary biliary cirrhosis. . . . . . . . . . . .......... . 
Survived 
1 yr. 
2 (17) 
3 (33) 
1 (11) 
o (0) 
Alivet 
now 
2 
a 
1 
Follow-up period 
present survivors, OT Nos. 
mos. oj survivors 
1S, 22 90,78 
20 82 
Secondary biliary cirrhosis. . .. . ................................... . 
No. 
12 
9 
9 
3 
1 
1 
1 
1 
o (0) 
Sclerosing cholangitis with ulcerative colitis ........................... . o (0) 
Massive hepatic necrosis due to hepatitis B virus ...................... . o (0) 
Budd-Chiari syndrome. . . .................................. . 1 (100) 
7 (19) 
1 
4 
13 
13-22 
93 
Total. . .......... .. . . ................................. . 37 
Figures in parentheses represent percentages. 
The patient with massive hepatic necrosis and two of the patients with chronic aggressive hepatitis had HBsAg positive tests preoperatively. 
*Included seven liver cell carcinomas-three with cirrhosis-three duct cell carcinomas at the confluence of the right and left hepatic ducts which caused 
complete bile ohstruction, one cholangiocarcinoma and one hemangioendothelial sarcoma. The t\\'o patients who are still alive had small obstructing duct 
cell carcinomas, but in one of these, there have been hepatic recurrences after 21 months. 
tThe foul' d.eaths after one year occurred after 12, 13}1, 19 and 20Y:i months. Causes afe given in text and in Table VI. 
perfused with 1 to 3 liters of a chilled electrolyte 
solution through the portal vein just before and 
after organ removal (31). Sometimes, the livers of 
adults and large adolescents may be more effec-
tively cooled by connecting these cadaveric donors 
to a cardiopulmonary bypass into which a tempera-
ture reducing heat exchanger has been placed (31). 
Even after such preliminary total body chilling by 
means of a heart-lung machine, a final intraportal 
infusion of cold electrolyte solution is used. Inci-
dentally, the technique of hypothermic cardio-
pulmonary bypass is excellcnt to rescue cadaveric 
donors who become unstable in the hours preccding 
the transplantation or in the course of removing the 
liver. 
The HL-A match was not used as a criterion of 
donor-recipient selection, but these data were 
obtained in all instances since 1964. Major incom-
patibilities were present in all but a handful of 
patients (Table III). The quality of HL-A match-
ing has not seemed to influence the outcome, al-
though the scarcity of good matches has reduced 
the meaning of such a correlation. 
Preformed antired cell isoagglutinins that react 
against donor tissues and cytotoxins, which can be 
detected by their lysis of donor lymphocytes, im-
mediately destroy many rcnal homografts that are 
transplanted in violation of such positive cross 
matches. The liver is resistant to this so-called 
hyperacute rejcction (26). In our serics, three livcr 
transplantations were carried out in spite of red 
blood group incompatibility and three more were 
performed in confrontation of cytotoxic antibodies 
(Table III). There were no unequivocal hyper-
acute rejections. An account of this expericnce is 
being published separately. 
Other modifications of technique or changes in 
our past policy should be mentioned. Originally, 
splenectomy was pcrformed at the time of trans-
plantation if this procedure had not already been 
carried out at an earlier time and if it was con-
sidered to be safe. Of the first 80 patients, four had 
prior and 57 concomitant splenectomy. In the last 
13 patients of this report, splenectomy was omitted. 
Host hepatectomy is usually still pcrformed by 
individually dissecting the hilar structures and thc 
vena cava abovc and below the liver and by then 
cross clamping and dividing the vessels just as the 
liver is removed (29, 31). However, in some adults, 
a safer way has been to transect first the hilar struc-
tures and, subsequently, the infrahcpatic inferior 
vena cava when all else is in readiness (Fig. 1). 
Then, by pulling on elamps which are placed on 
the hepatic side of these structures, the liver is dis-
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FIG. 1. Technique of retrograde removal of linT. A, Incisions. A.A, Subcostal inci-
sion used for all orthotopic liver transplantations. BB, CC and DlJ, Frequently used 
extensions from the AA incision. B. Beginning retrograde removal after transection 
of inferior vena cava and hilar structures. All posterior tissue that is cut should be 
ligated, although the named vessels encountered, such as the right adrenal vein, are 
few in number. 
sected free from below to above, ligating all cut tis-
sues on the way (Figs. 1 and 2). The suprahepatic 
inferior vena cava remains intact as the stalk of the 
specimen until it is clamped just before the liver is 
removed. This variation in operation has been 
particularly useful in developing a reasonably long 
suprahepatic cuff of the inferior vena cava in 
adults. The vena cava or main hepatic veins may 
be dissected free from within the cirrhotic liver in a 
bloodless field (Fig. 2B). 
In several of our first recipients who did not have 
biliary atresia, bile duct reconstruction was with 
choledochocholedochostomy over aT-tube stent 
(Fig. 3D). The method lost favor because of a high 
incidence of bile fistula, and cholccystoduodenos-
tomy after ligation of the common duct (Fig. 3A) 
became our first choice for a number of years. How-
ever, since November 1973, the preferred technique 
has been cholecystojejunostomy with a Roux-en-Y 
loop (Fig. 3B), thus removing the homograft from 
the mainstream of the gastrointestinal tract and 
draining it through a defunctionalized jejunal 
limb. Alternatively, Roux-en-Y choledochojejun-
ostomy (Fig. 3C) or choledochocholedochostomy 
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Anterior 
surface of 
cirrhotic liver 
FIG. 2. A, Operative field after retrograde liver mobilization. The last remaining 
structure, the suprahepatic inferior vena cava, has been clamped above the liver. 
B, Technique for mobilizing a suitable length of suprahepatic vena cava after place-
ment of clamp. In adults, this usually involves cutting away cirrhotic liver tissue 
over the frequently distorted and foreshortened right and left hepatic veins. 
(Fig. 3D) has been used for recently treated pa-
tients. In a number of patients, it has becn neces-
sary to convert from cholecystojejunostomy to 
eholedoehojejunostomy (Fig. 3B and C) because of 
obstruction at the cystic duct (17). 
The first five patients were treated with aza-
thioprine and prednisone. The next 88 recipients 
were given triple drug immunosuppression, which 
usually consisted of azathioprine and prednisone, 
to which a two weeks to four months' course of 
horse antilymphocyte globulin was added (31). If 
hepatotoxicity of azathioprine was suspected, cyclo-
phosphamide was substituted, since it has an im-
munosuppressive effect comparable with that of 
azathioprine (32). In a number of later patients, 
cyclophosphamide was used at the beginning with 
a switch later to azathioprine. 
Histopathologic Studzes and Clinical Correlations 
During the 12:Y2 years of study, samples were 
accumulated from the diseased native livers, homo-
grafts and selected other tissues and fixed in 10 per 
cent buffered Formalin (aqueous solution of form-
aldehyde). Frozen sections were stained with Sudan 
IV for fat, and then, the remainder was processed 
and the paraffin sections were stained with h~ma­
toxylin and eosin, Gordon and Sweet's silver im-
pregnation method for reticulin fibers, Perls' 
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FIG. 3. Techniques of biliary duct reconstruction used for most of the transplantation recipients. 
A, Cholecystoduodenostomy. B, Cholecystojejunostomy. C, Choledochojejunostomy after removal 
of gallbladder. D, Choledochocholedochostomy. Note that the T-tube is placed, if possible, in re-
cipient common duct. 
Prussian blue method for iron, Weigert's for elastic 
counter-stained with hematoxylin and van Gieson, 
trichrome for collagen and fibrin, periodic acid-
Schiff method for glycogen, Pearse's method for 
ceroid and lipofuscin, and methyl green pyronin. 
Frequently, additional small hepatic samples 
were initially fixed in glutaraldehyde solution, and 
then postfixed in osmic acid and embedded in Epon, 
a synthetic embedding medium. Half micron and 
ultrathin sections were cut. The former were stained 
with azure II for examination in the light micro-
scope, while the latter were stained with lead citrate 
and examined in a Phillips 300 electron microscope. 
Many of the findings in the liver grafts have been 
reported before (21). In preparing this survey, the 
old specimens were fe-examined, and new ones 
were analyzed. Clinicopathologic correlations were 
made, so that a final judgment could be made in 
each about the reasons for failure. The most impor-
tant element in the final decision was the state of 
the homograft and the evidence in it of injury from 
an old or a new rejection. The clinical course and 
the findings of the autopsy also were taken into 
considera tion. 
An effort to assign a single, most important cause 
of failure inevitably required oversimplification, 
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a b 
FIG. 4. Acute rejection. Hepatic homograft, OT 31, nine days after transplantation. Large nUtll-
bers of lymphoid cells are present in the portal tracts and between the damaged hepatocytes. Hema-
toxylin and eosin, a, X300; b, X500. 
since the terminal events were always complex. 
Thus, although infection almost invariably played 
an important role at the end, as has been empha-
sized before (17, 25, 31), infections are not men-
tioned hereinafter unless they seemed to play a 
triggering and primary role. The all important role 
of infection in these same patients is to be described 
in a detailed separate publication. 
The effects of hepatic homograft rejection and 
other postoperative events upon liver function tests 
have been exhaustively described by us (17, 25, 29, 
31) and by \Villiams and his associates (35). The 
abnormalities of function with rejection are not 
diagnostic, since the profile of tests may range 
from a pattern of obstruction to one of parenchymal 
necrosis. The single most important test in observ-
ing the patients has proyed to be serum bilirubin 
concentration, which frequently will be referred 
to in the clinicopathologic correlations. 
TABLE III.-HL-A TYPI-"G OF PRnlARY GRAFTS 1-" 
93 PATIENTS 
Survival, Alive 
Matclt* No. one year now 
A 1 1 t 0 
B ......... 2 1 (50) 0 
C. .......... 14 3 (21) 2 (14) 
D ...... 23 5 (22) 3 (13) 
E .. ............ 40 15 (38) 11 (28) 
F ... 6 1 (17) 0 
Not done .. ..... , .. , , 7 1 (14) 0 
Total. ........ , .. 93 27 (29) 16 (17) 
Figures in parentheses represent percentages .. 
*A-match: HL-A identify between recipient and donor; B-mrttch: com-
patibility betv,.een donor and recipient, but fewer antigens determined in 
the donor; C-rnatch: one antigen incompatible; D-match: two antigens in. 
compatible; E-rnatch: three or four antigens incompatible, and F-match: 
ABO violation or positive cross match to cytotoxic antibodies. 
fRetransplanted after 68 days with C-match graft. Thus, the one year 
survival was mainly due to the second less well matched organ. . 
RESULTS 
Pediatric Patients 
Othtr than biliary atresia . .:\ine of the 16 patients 
lived for at least one year after transplantation. The 
seven others who received a total of eight grafts 
died after one to 188 days. Acute rejection (Fig. 4) 
was directly responsible for one of these seven 
deaths (Table IV). Late rejection (Fig. 5) of a 
primary graft indirectly led to another death, inas-
much as a retransplantation became necessary and 
was not successful in spite of the fact that the second 
organ was not rejected (Table IV). The non-
immunologic factors of biliary obstruction, tumor 
recurrence, perforation of a colonic diverticulum 
and ischemic liver necrosis were responsible for the 
other fatalities that occurred within the first year 
(Table IV). 
Shortly after one year (Table IV), two more 
patients died with recurrences of the hepatomas for 
which the transplantations had been pC'fformed. 
In one of these li\'ers, biliary obstruction developed 
as the result of a metastasis, and the other one con-
tained evidence of chronic rejection, for which 
retransplantation was attempted. A third child 
died 26 months after liver replacement for chronic 
aggressive hepatitis. At autopsy, a stricture was 
found at the choledochocholedochostomy site, with 
dilatation of the duct system which was packed 
with inspissated bile and debris (Fig. 6). There was 
no evidence of rejection. The mechanical problem 
probably could have been corrected if it had been 
diagnosed. Transhepatic cholangiography had 
been attempted four times in the six months before 
death, but the duct system was not entered. 
The last late death occurred six years after trans-
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FIG. 5. Chronic rejection. a, A small hepatic artery branch in a graft, 0'1' 16b, 339 days after 
retransplantation is almost occluded by intimal thickening. Elastic stain, X60. b, Residual scarring 
after rejection. Same graft, OT 16b. There is increased portal fibrous tissue and connective tissue 
septums extend into the lobules. Reticulin, X 60. c, Centrilobular cholestasis with bile "thrombi" in 
dilated canaliculi in graft, OT 14a, one year and 16 days after transplantation. Bile stain, X200. 
d, Collapse of reticulin fiber framework around central veins in graft, OT 10, 186 days after trans-
plantation. Reticulin, X60. 
plantation. The original diagnosis in this patient 
was Wilson's disease. After liver replacement, the 
homograft had no tendency to accumulate copper 
(30). About four years postoperatively, the patient 
was thought to have discontinued the immuno-
suppressive therapy for several months. Liver func-
tion, which had been perfect, deteriorated, and he 
became jaundiced. Resumption of trcatment did 
not reverse the process in spite of the fact that the 
liver biopsy now had relatively minor abnormali-
ties. Because a transhepatic cholangiogram showed 
a partial biliary obstruction, bile duct reconstruc-
tion was revised with conversion of cholecysto-
duodenostomy to choledochojej unostomy; jaundice 
persisted. At autopsy, almost two years later, the 
main finding in the liver homograft was cholestasis, 
similar to that seen in Figure 6, suggestive of 
chronic bile duct obstruction. 
Five of the 16 recipients in this nonatresia pedia-
tric subgroup are still alive after 13 months to al-
most five years (Table I). Each attends junior high 
school, high school or a university. They all have 
normal, or nearly normal, liver function, with 
serum bilirubin concentrations ranging from 0.5 to 
1.5 milligrams per cent. 
One of these patients who is now well became 
deeply jaundiced and profoundly ill almost a year 
and a half after transplantation. A liver biopsy was 
interpreted as showing drug toxicity (Fig. 7). 
Cyclophosphamide was substituted for azathio-
/ 
__ 0 ...-. 
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FIG. 6. Large bile duct obstruction. a, Biliary cast syn-
drome in graft, OT 55, two years and two months after 
transplantation. The wall of the distended bile duct is 
fibrous, and the lumen is blocked by inspissated bile and 
debris. Hematoxylin and eosin, X60. b, Biliary cast syn-
drome in graft, OT 43, 47 days after transplantation. A 
portal tract is greatly expanded and an intrahepatic bile 
duct is blocked by inspissated bile. Hematoxylin and eosin, 
X50. c, Chronic large duct biliary obstruction. Enlargcd 
fibrous portal tract with proliferated bile ductules contain-
ing bile casts. Hematoxylin and eosin, X70. 
prine with subsequent slow improvement of liver 
function during the next few months (Fig. 8). 
Biliary atresia. The 40 recipients were given a 
total of 45 livers. One of the second grafts was from 
a chimpanzee (26, 30). The other four organs for 
retransplantation were from cadavers as were all 
the 40 primary grafts. The one year survival figure 
was 11 of 40 patients or 28 per cent. 
In a recent publication, clinical or pathologic 
analyses were given for each of the 40 individual 
patients (30). Our interpretations from that raw 
data of the main reasons for graft losses and deaths 
b 
are summarized in Table V. The complications 
came in progressive waves, to which specific 
etiologic factors selectively contributed at succes-
sive times. 
Aeute problems of surgical technique or manage-
ment were the most common causes of failure and 
resulted in the deaths of 11 children ill 5.7 ± 6.6 
(S.D.) days, range zero to 20. Graft vascular 
thrombosis, bleeding and the use of necrotic livers 
headed the list Cfable V). The deaths occurred 
too soon to permit an effect upon the pre-existing 
jaundice, except in a child in whom the hepatic 
artery clotted but who had the longest survival time 
of 20 days. The serum bilirubin level fell promptly 
and was 1.5 milligrams per cent just before death, 
which resulted from infection in multiple areas of 
liver necrosis. Birtch and Moore (4) have reported 
a similar experience of survival of 45 days by a 
patient who had a dearterialized and partly 
necrotic but functioning homograft. The recipient 
of the chimpanzee heterograft had a serum bili-
rubin concentration of 14 milligrams per cent after 
14 days when he died from the pulmonary "nsuffi-
ciency that had been present since the time of 
retransplantation. 
Another seven children died after 60.9 ± 22.9 
(S.D.) days from additional mechanical complica-
tions which usually involved the reconstructed 
biliary duct system in one of the ways shown in 
Figure 9 and which were not immediately lethal 
(Table V). Infection was the usual final event in 
the downhill course. The last serum bilirubin con-
centrations in these patients were 9.9±6.1 (S.D.) 
milligrams per cent, range 3 to 22. There was no 
histopathologic evidence of rejection in any of the 
grafts, nor was cholangitis a prominent feature. 
Virus infestation of the cells lining the bile duclules 
or of the hepatocytes was diagnosed in three of 
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these seven livers (Fig. 10). It has been suggested by 
Martineau and his associates (17) that such virus 
infestation of the biliary tree can cause swelling, 
necrosis and shedding of the infected cells to form 
obstructing casts. 
The foregoing pooled 18 examples of predomi-
nantly technical or mechanical difficulties ac-
counted for 55 per cent of all the deaths in the 
atresia experience. The staggering total actually 
may have understated the true contribution of 
surgical technical complications to the failures, 
since it excluded the four examples of septic hepatic 
infarction (Table V) in which portions of the liver 
became de arterialized and necrotic with invasion 
by bacteria from the intestinal tract. The latter 
complication has been suggested to be due to a 
combination of insufficient immunosuppression 
plus technical or mechanical factors which twist or 
otherwise jeopardize the hepatic arterial patency 
(25, 31). 
Rejection played a surprisingly minor role in 
causing graft loss or death, at least insofar as this 
could be detectcd by histopathologic examination. 
Four patients acutely rejected the primary graft 
(Fig. 4) after 17.3±11.0 (S.D.) days. The last 
serum bilirubin concentrations were 17.8 ± 7.5 
(S.D.) milligrams per cent, range 13 to 29. 
Three grafts were designated as being lost 
primarily from chronic rejection because of thc 
severe arterial narrowing, lymphoid cell infiltra-
tion and other findings that are characteristic of 
this process (Fig. 5). These transplants had been in 
place for two months to two and one-half years and 
were supporting serum bilirubin concentrations of 
19, 10 and 20 milligrams per cent. Three of the 
four livers that were lost primarily because of septic 
hepatic infarction had chronic rejection as well. 
Systemic infections or else infestations of the 
b 
C 
FIG. 7. Presumed drug toxicity. Biopsy of a graft in a pa-
tient, OT 74, who was deeply Jaundiced at one year and five 
months after transplantation. The liver functions returned 
to normal after azathioprine was replaced with cyclophos-
phamide and after the prednisone dosage was lowered to 
less than half of its previous level. a, Centrilobular hepato-
cytes are swollen and show abnormal variation in nuclear 
size. Hematoxylin and eosin, X200. b, Centrilobular chole-
stasis with bile thrombi in dilated canaliculi. Bile stain, 
X200. c, Normal portal tract. Hematoxylin and eosin, 
X200. 
homografts were thought to be the main causes of 
failure in eight patients, generally at an intermedi-
ate time. Concomitant chronic rejection had dam-
aged two of the homografts of the five patients who 
had lethal systemic infections (Table V). Serum 
bilirubin concentrations were variable in these 
eight instances, ranging from 1 to 52, with a mean 
of16.0±16.4 (S.D.) milligrams per cent. The three 
patients with infected livers had bilirubin levels of 
52, 15 and 10 milligrams per cent. 
One liver which was obtained from an anence-
phalic monster never cleared bilirubin. Ironically, 
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FIG. 8. The first two post-transplantation years of patient, OT 74. The second liver biopsy, which 
is shown in Figure 7, suggested drug toxicity. Substitution of cyclophosphamide for azathioprine and 
reductions in steroid dosage were followed by gradual resolution of the profound hyperbilirubinemia. 
it had the histopathologic findings of intrahepatic 
biliary atresia when it was removed 85 days later. 
An attempt at retransplantation failed when the 
hepatic artery of the second transplant clotted. 
Eleven or 28 per cent of the 40 patients survived 
for at least one year after operation, and seven are 
still alive with good or perfect function from their 
original hepatic homografts after 13, 15, 26, 34, 46, 
53 and 71 months (Table I). All are living essenti-
ally normal lives. Their return visits to Colorado 
range from every three to 12 months. :\"one are 
jaundiced. In two of these patients, serial biopsies 
were obtained. Some of the early specimens showed 
classical cell mediated rejection (30) which was 
readily controlled as judged by the final clinical 
outcome. As already recounted, the late deaths oc-
curred 12Y2, 13Y2, 30 and 41 months after trans-
plantation. 
Adult Patients 
Onlv seven or 19 per cent of the 37 adult recipi-
ents lived for as long as one year postoperatively. 
The results were not satisfactory after transplanta-
tion for any of the main indications for liver tran8-
plantation (Table II). Only one of nine alcoholics 
survived for as long as a year. Three of nine patients 
with chronic aggressive hepatitis lived for this long, 
as well as two of 12 patients with primary tumors of 
the liver·. Two patients in the malignant category 
are still alive 15 and 22 months after liver replace-
ment for the small intrahepatic duct cell carci-
nomas described by Klatskin (15) that obstruct the 
confluence of the right and left hepatic ducts and 
cause early jaundice. The recipient with the longer 
follow-up period has multiple recurrences in the 
transplanted liver. The patient (Table II) who had 
the Budd-Chiari syndrome is the only one with this 
diagnosis known to have been treated with liver 
transplan ta tion. 
In Table VI, a single principal reason was iden-
tified for the loss of each of the 35 homo grafts that 
were transplanted to the 33 adult recipients who 
eventually died. Seventeen of the recipients or 59 
per cent of the 29 who died in the first postopera-
tive year had lethal complications which had their 
genesis intraoperatively or just afterward (Table 
VI). 
Eleven of these 17 early accident;; were classed as 
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FIG. 9. Examples revealed by transhepatic cholangiography of homograft cystic 
duct obstruction after biliary reconstruction with cholecystoenterostomy. a, Original 
procedure was cholecystoduodenostomy. After this transhepatic cholangiogram, 
conversion was made to choledochoduodenostomy. At operation, the fi lling defect 
near the exit of the cystic duct was found to consist of a chalk-like sludge. There was 
not complete relief of jaundice. \.yhen the patient died 13 months after transplanta-
tion, the homograft still had intrahepatic evidence of large duct obstruction . b, The 
original reconstruction was with cholecysto-Roux-en-Y-jejunostomy. This was con-
verted to a choledochojejunostomy. The p a tient is well a year latcr. c, The original 
reconstruction was with cholecysto-Roux-en-Y-jejunostomy. This was con verted to 
a choledochojejunostomy. The patient is well about two years later. CD, Common 
bile duct; CyD, cystic duct; GB, gallbladder, and J, Roux-en-Y limb of jejunum. 
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technica l and led to death in 19.8 ± 11.4 (S.D .) 
days. Only one of these 11 patients was not jaun-
diced before death. The other ten had final serum 
bilirubin concentrations that ranged from 7 to 46 
milligrams per cent, with a mean of 26.8 ± 12.7 
(S .D.) . Three of the patients were given livers that 
were irreparably damaged by ischemia in opera-
tions that were 10niS and bloody. The grZlfts of 
three more recipients were ruined by tying ofr an 
anomalous double barreled channel of cystic and 
common duct preparatory to performance of chole-
cystoenterostomy (31) . The complication was not 
recognized or treated in two patients. An attempt 
to relieve the consequen t total biliary obstruction 
in the third patient resulted in a bile fistula and 
lethal peritonitis. In five more patients, bile fistulas 
developed with peritonitis, and they died after 13 
to 34 days. The leaks were at the site of choledoeho-
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FIG. 10. Virus infestation of cells lining bile ducts. a, Several bile ducts obstructed by 'swollen virus 
infected cells in an expanded portal tract in a liver graft, OT 30, 37 days after transplantation. Hema-
toxylin and eosin. X 50. b, Detail of similar obstructed duct in another infected graft, OT 44, shows 
enlarged lining eoithelial cells containing nuclear inclusions. Cytomegalovirus was identified in this 
liver. Hematoxylin and eosin, X700. 
choledochostomy or at the T-tube insertion site 
in four instances. The fifth fistula was caused by 
necrosis of the gallbladder after cholecystoenteros-
tomy. 
Cerebrovascular accidents accounted for six 
other puzzling intraoperative or early postopera-
tive complications. Two of the patients were in 
Stage IV hepatic coma at the time of operation, 
but the other four were more or less alert. After 
operation, five of the six recipients, including one 
in previous coma, had a lucid interval that lasted 
from a few hours to three days before they were 
crippled by neurologic disabilities that were sug-
gestive of major brain stem damage. The trans-
plant operations in each instance had been long 
and difficult, with many blood transfusions which 
further reduced thrombocyte counts that had 
already been low. The neurologic damage was so 
profound in each instance that death followed 
within a few days, or else a decision was later 
made to stop active treatment. The six patients 
died after 21.7±14.8 (S.D.) days, range 3 to 41. 
By then, two patients had serum bilirubin con-
centrations of 28 and 7 milligrams per cent, 
respectively, but the other four had bilirubin values 
which ranged from 0.7 to 2.7 milligrams per cent. 
All the liver grafts were free of rejection, and two 
were completely normal. The brains had areas of 
myelinolysis in the brain stem. In addition, there 
were other cortical and subcortical abnormalities in 
some of the brains. These latter included small 
hemorrhages, infarcts and edema. 
There were seven deaths 17.3±9.8 (S.D.) days 
after transplantation from systemic infections which 
usually reflected the poor preoperative state of the 
patients. Two were receiving second grafts, one 
patient had candidemia at the time of transplanta-
tion, one was a fragile end-stage alcoholic and 
three were patients who were treated early in our 
experience before infectious disease care under 
conditions of immunosuppression had been stan-
dardized. Two of these last three patients had also 
had pulmonary embolization from clots which had 
formed in a venovenous bypass tube which is no 
longer used (29). The final serum bilirubin con-
centrations were variable, ranging from 1.5 to 22 
milligrams per cent, with a mean of 9.9±7.6 
(S.D.). 
At an intermediate time of 209 ± 221 (S.D.) 
days, ranging from 47 to 564 days, six grafts were 
retrieved by death or retransplantation that had 
histopathologic findings of extrahepatic biliary ob-
struction. The original biliary duct reconstruction 
was with cholecystoduodenostomy or Roux-en-Y 
cholecystojejunostomy. There was clinical evi-
dence of adequate bile excretion initially. However, 
it was either proved later in four patients or as-
sumed in retrospect that the site of obstruction was 
at the cystic duct, as shown in Figure 9. Reopera-
tion was performed in four patients, and a secon-
dary choledochoenterostomy was attempted with 
what was thought to be success. However, histo-
pathologic findings persisted within the liver of 
large bile duct obstruction weeks or months later. 
Furthermore, jaundice was not permanently re-
lieved. The final mean serum bilirubin concentra-
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FIG. 11. Patterns ofliver injury not thought to be rejection or obstruction. a, Focal arcas of necrosis, 
OT 69. Hematoxylin and eosin, X60. b, Acute vcnous congestion, OT 17. Hematoxylin and eosin, 
X60. c, Centrilobular cholestasis with bile thrombi, OT 97. There was no evidence oflarge duct ob-
struction, drug toxicity or rejection in this patient. Hematoxylin and eosin, X200. d, Diffuse fatty 
infiltration of hepatocytes, OT 94. Frozcn section stained with Sudan IV, X60. 
tion reflecting the function of these grafts was 
18.4±8.4 (S.D.) milligrams per cent, range 5 to 
28. Two of these apparently obstructed hepatic 
homografts were removed after 564 and 111 days 
and replaced under the probably erroneous as-
sumption that they had been rejected. The patients 
died 11 and 22 days later. 
The most surprising observation was that only 
one of the 35 livers transplanted to adult recipients 
contained the classical findings of acute cell medi-
ated rejection. Four other grafts contained residual 
changes of acute rejection or evidence of repair 
following this process, but rejection was not con-
sidered to be the main cause of failure. Further-
more, there were no examples of chronic rejection. 
However, only three of the remaining 30 livers 
were structurally normal. The majority of the 
others contained such diverse and nonspecific find-
ings (Fig. 11) as fatty infiltration, venous conges-
tion, centrilobular cholestasis, atrophy or necrosis 
of the centrilobular hepatocytes and focal necrosis 
or infarction that were thought to be secondary to 
ischemia or sepsis. One liver had severe centrilobu-
lar atrophy and reticulin collapse at the time of 
death from hepatic failure after 161 days. A con-
vincing final diagnosis was not made. Several livers 
were infested with cytomegalovirus particles (Fig. 
10) which were in hepatocytes and in the cells 
lining ducts. 
Two hepatic grafts were invaded with recurrent 
malignant tumors of the same kind that had 
destroyed the native liver, leading to death after 
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TABLE IV. -CAUSES OF DEATH 1:\ 11 PEDIATRIC 
PATIENTS WITHOUT BILIARY ATRESIA 
Time 
of 
OT death, 
No. days iVI ain cause oj death 
20 1 Ischemic liver necrosis 
31 9 Acute liver failure 
44 34 Biliary obstruc tion, 
unrecognized 
41 61 Biliary obstruction, 
corrected 
57 64 Perforated diverticulum 
colon 
Rejection 
Ko. 
Yes 
No 
No 
No 
Last 
bilirubin 
determination, 
mgm. 
per cent 
30 
14 
13 
3 
23 143 Hepatoma recurrences* No 40 
65 188 Infection after second Yes healing, 
transplantation at first 17 
157 days No, second 1.5 
8 400 Hepatoma recurrences;* No 15 
bile obstruction 
14 436 Hepatoma recurrences;* Yes healing, 
chronic rejection; first 34 
complications after No, second 5 
second transplantation 
at 379 days 
55 780 Biliary obstruction, No 30 
unrecognized 
27 2190 Chronic liver failure; Yes healed 16 
bile obstruction 
*Hepatoma was original disease. 
349 and 87 days. One was a hepatoma and the 
other was a hemangioendothelial sarcoma. 
Four of the seven patients who survived for one 
year are still alive with follow-up periods of 13 to 
22 months. They have perfect liver function. All 
four live at home and work full time or attend 
schoo!. The patient with the longest follow-up 
period has recurrences of intrahepatic duct cell 
carcinoma. 
The threc deaths after one yeClr were at 13>-:2, 
19Y2, and 20Y2 months. All were patients whose 
original diagnosis was chronic aggressive hepatitis. 
However, recurrence of the Clggressive hepatitis was 
observed only in the recipient who was an HBsAg 
virus carrier (Fig. 12). CandidiClsis and nocardiosis 
contributed to her death as Corman and his asso-
ciates have reported (7). In the other two recipi-
ents, the grafts were destroyed by the biliary ob-
struction already cited, which was not recognized 
in one instance leading to an ill-advised retrans-
plantation and which was apparently not effcctive-
ly treated in the other. 
DISCUSSION 
In a positive sense, the most important conclusion 
that has emerged from this experience with liver 
replacemel1 twas tha t prolonged sllrvi val repeatedly 
was possible. A total of 27 patients lived for at least 
a year following operation, and 16 of this group 
are still alive after more than one to almost six 
years. The outlook has slowly improved, although 
not to a satisfactory state. The first 25 recipients 
who formed the basis of a monograph on liver 
transplantation (31) included only five one year 
survivors. The next group of 25 contained six, and 
the group after that had eight. There have already 
been eight one year survivors among the 18 pa-
tients beginning with No. 76. 
The chronic survivors, particularly those in re-
cent times, have had remarkably stable liver func-
tion, and usually, they have achieved complete 
social rehabilitation. Survival of more than a year 
after orthotopic liver transplantation has been 
recorded from other centers by Williams (35), 
V,r aldram and Caine and their associates (34) in 
England, by Daloze and his colleagues (8) 1 in 
CanClda and by Hume and his associates (12) in the 
United States. 
One reason the results were not better was the 
great technical difficulty of performing orthotopic 
liver transplantation under the trying conditions of 
end-stage hepatic disease with consequent portal 
hypertension and multiple coagulation and meta-
bolic defects. Even excluding the biliary duct com-
plications, about a fourth of the patients who died 
left the operating room with situations thClt were in-
compatible with survival, such as ischemic liver 
necrosis, graft vascular thrombosis and uncon-
trolled hemorrhage. The mortality from technical 
accidents involving vessels was particularly high in 
infants with biliary atresia, partly because of the 
small size of the structures for anastomosis. The 
recent use of microsurgical techniques has almost 
completely eliminated such losses. In future trials, 
children with a wide rangc of diseases, including 
biliary atresia, undoubtedly will be the most 
favorable group of recipients. 
More critical questions must be asked about the 
six crippling cerebrovascular accidents which con-
stituted the single most common lethal complica-
tion intraoperatiwly and carly postoperatively 
among the 37 adults. The most consistent, although 
not the only, damage was found in the brain stem 
and consisted of the kind of myelinolysis that is 
as~ociated with end-stage liver disease. \Villiams 
and his associates (35) also may have encountered 
cerebrovascular accidents, inasmuch as two of their 
26 recipients failed to awaken from anesthesia. 
Lampe and his co-workers (16) have reported a 
serious, but partly reversible, diffuse brain injury 
in an 11 year old recipient of an orthotopic liver. 
IThe patient described in this report is alive one and one-half 
years after transplantation. The other two one year survivors in the 
"t\1ontreal series of six patients died after two and three-quarters and 
three and three-quarters years as learned from personal commu-
nication on 3 December, 1975. 
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FIG. 12. Recurrence of viral hepatitis. a, Hepatitis affecting graft, OT 36. Hematoxylin and eosin, 
X250. b, Same graft stained with orcein. Granular material is present in the hepatocyte cytoplasm. 
This usually indicates the presence of hepatitis B viral antigen. Shikata stain, X300. 
They as'cribed the complication to intraoperative 
hyperosmolarity that had been caused by excessive 
glucose administration. Hyperglycemia was not a 
regular feature of our patients, although it was 
present in some of them. Intraoperative thrombo-
cytopenia and hypocoagulability may have led to 
small hemorrhages into areas of pre-existing brain 
disease. Air embolus as the causation has not been 
ruled out. The neuropathologic findings in these 
autopsies are being restudied, so that preventive 
measures may be developed for future patients. In 
the meanwhile, the high risk of brain damage in 
adult patients who had a wide variety of diagnoses 
suggests that as a general policy candidacy for 
transplantation was being considered too late in 
the terminal course of the disease. 
In the livers that were eventually retrieved for 
study by death of the recipient or removal at re-
transplantation, a potentially encouraging but per-
plexing observation was the paucity of unequivocal 
findings of either acute or chronic rejection. Early 
biopsies from a few of these grafts contained the 
unmistakable lymphoid infiltrations of acute cell 
mediated rejection (30, 31), but this process usually 
had been controlled at least by histopathologic 
criteria by the time the whole organ was examined. 
Moreover, the kind of chronic rejection that has 
been so well described in dogs (21, 28) and which 
is characterized by obliterative vascular lesions 
with or without lymphoid infiltration and fibrosis 
was not common either. 
About one in four of all the grafts studied had 
strong histopathologic evidence of large bile duct 
obstruction, and in most of these instances, there 
was confirmation that such mechanical problems 
had been present from premortem clinical studies 
or from postmortem gross examination. Some of 
the livers had demonstrable infestation and injury 
by bacteria, fungi or viruses. However, the majority 
of the livers contained changes that might be con-
sidered nonspecific under other circumstances. 
Examples were fatty infiltration, venous conges-
tion, centrilobular cholestasis, centrilobular atrophy 
or necrosis and focal necrosis or infarction. 
The interpretation from these findings may prove 
to be that liver recipients are being systematically 
overimmunosuppressed, particularly since, as a 
final event, almost all liver recipients who die have 
significant extrahepatic infections (31). If over-
treatment is the problem, a change in management 
policy will be called for, whereby lightening in-
stead of intensification of immunosuppression 
would usually be an appropriate response to de-
terioration of postoperative liver function. 
This kind of radical approach can hardly be 
justified yet since many patients with a graft that 
is failing early after transplantation respond to in-
creased dosages of prednisone. It may be that some 
of the structural abnormalities that are presently 
thought to be nonspecific are actually subtle mani-
festations of hepatic rejection or recovery from this 
process. Such an interpretation would fit with ob-
servations in dogs that start to recover from rejec-
tion, either spontaneously or as a result of treatment 
with immunosuppressive drugs (11, 21, 28, 31). 
Characteristically, the homografts of such animals 
lose the lymphoid cell infiltration and develop 
prominent centrilobular bile stasis, atrophy of the 
centrilobular hepatocytes, collapse and condensa-
tion of the centrilobular reticulin and increased 
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TABLE V.-REASONS FOR 37 ORTHOTOPIC HOMO-
GRAFTS AND ONE CHIMPANZEE HETEROGRAFT 
BEING LOST AFTER TRANSPLANTATION INTO 33 
CHILDREN WITH BILIARY ATRESIA WHO EVEN-
TUALLY DIED 
No. of Time to death 
exam- Or graft loss, 
Category pies days aT No. 
Acute technical or 
management. 11 
Hepatic artery clot (3) 4,20, 1 18, 38, 52b 
Hemorrhage (2). 0,2 1,76b 
Graft necrotic (2) .... 11, 2 241 48 
Portal vein clot (1) ... 1 21 
Outflow venous 
obstruction (1) .... 7 34 
Uncorrected 
hypovolemia (1) ... 80 
Pulmonary 
insufficiency (1)§ ... 14 71b 
Delayed technical ....... 7 
Biliary 
obstruction (4)* ... 37,47,73,84 30, 43, 49, 84 
Biliary fistula (2)* . 81, 28 4.7,68 
Fungus peritonitis and 
traumatic 
pancreatitis (1) .. 76 26 
Acute rejection ...... 4 
7, 31, 10, 21 7,50, 71a, 86 
Chronic rejection ........ 3 
881·, 65, 339 13a, 16a, 16b 
Septic hepatic infarction .. 4t 
133, 186,61, 105 9,10,11,12 
Infection of graft ..... 3 
Hepatitis (2). 377,33 29, 76a 
Aspergillus (1). 20 13b 
Systemic infection. 5:1: 
? gram-negative 
bacillus (2) ..... 36, 175 35, 59 
Hemophilus (1). 1238 19 
Nocardia and 
Candida (1) . 51 37 
Herpes (1) .. 59 67 
Transplantation of liver 
with atresia ........ 85 52a 
a, Primary graft in patient who underwent retransplantation; b, second 
graft. 
*Eile duct reconstruction was attempted in three of these six patients but 
unsuccessfully. 
tThree of these four livers had vascular or other findings of chronic 
rejection. 
!Two of these five livers had vascular findings of chronic rejection. 
§This child received a chimpanzee heterograft at retransplantation. 
amounts of reticulin and collagen in the portal 
tracts. Besides any, or all, of these findings, fat 
deposition is not uncommon. 
Similar observations, including centrilobular bile 
stasis, have been made in the homografts of un-
treated, but long surviving, pigs by Hunt (13) and 
Battersby and his colleagues (2) and in treated 
baboons by Myburgh and his associates (19). Auto-
grafts of dog livers reported by us (31), Alican and 
Hardy (1) and McBride and his associates (18) did 
not have the cholestatic or other findings. The same 
absence of these findings in pig and baboon hepatic 
autografts has been described by Battersby (2) and 
Myburgh (19) and their colleagues. 
The critical and, as yet, unanswered questions 
are whether or not the foregoing changes in homo-
grafts and particularly the finding of intrahepatic 
cholestasis could represent ongoing rejection and, 
if so, how? Myburgh and his associates (19) have 
suggested the possible dynamic and immunologic 
nature of the cholestatic lesion on the basis of their 
own observations as well as a more general hypoth-
esis of Schaffner and Popper (22). In essence, 
their argument holds that a continuous and often 
sublethal injury to the hepatocytes is mediated by 
humoral antibody or by small numbers of leftover 
lymphoid cells. The hypothesis continues that 
hepatocyte organelles, including the smooth endo-
plasmic reticulum, are damaged, causing perturba-
tions in the secretion and relative concentrations of 
bile salts, cholesterol, phospholipids and bilirubin 
with the consequent formation of intrahepatic 
sludge and the establishment then of a reinforcing 
vicious cycle of sludging and obstruction. Studies 
will need to be designed to test this potentially im-
portant theory, an extension of which Waldram and 
his colleagues (34) have applied to partially ex-
plain sludge formation in the large bile ducts. 
Unfortunately, similar histopathologic abnor-
malities can be caused by many agents. Fahrlander 
and his co-workers (9) reported that, in eight pa-
tients, severe bacterial infection of organs other 
than the liver caused intrahepatic cholestasis with 
minimum hepatocellular injury or inflammation. 
Electron micrographs revealed dilatation of the 
canaliculi and rough endoplasmic reticulum. A 
clinical syndrome of liver failure associated with 
infection recently reported by Norton and his col-
leagues (20) may well represent a more severe 
version of the same process. 
It is self evident that intrahepatic cholestasis or 
the other manifestations of liver injury could also 
be caused by drugs, particularly those used for im-
munosuppression. The possibility that either aza-
thioprine or prednisone can harm animal or human 
livers was already well known a decade ago (27, 31) 
from experience in kidney transplantation, al-
though there was, at that time, no good way of sep-
arating out the instances of serum hepatitis. \Vith 
the development of the HB.Ag screening tests by 
Blumberg and his co-authors (5), Torisu and his 
associates (33) were able to survey the serums of 83 
of our renal recipients. Because serial serum samples 
had been systematically stored, it was possible to 
develop a longitudinal profile of the HBsAg state 
going back as long as five or six years. The serum of 
nearly 20 per cent of the patients had become 
HBsAg positive, but the ultimate incidence of 
severe liver disease in this group was not substanti-
ally different from that in the kidney recipients who 
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had been consistently HBsAg negative. Because of 
these observations incriminating factors other than 
serum hepatitis in the cause of post-transplantation 
hepatic dysfunction, a number of our renal re-
cipients with serious postoperative liver impairment 
have been switched to cyclophosphamide (32). The 
improvement that may follow in the hepatic state 
without deterioration of renal hemograft function 
has been confirmed by Berne and his associates 
(3) and in at least one of the liver recipients herein 
reported. A similar program of drug change in liver 
recipients with hepatic malfunction is likely to be 
important in future patients, notwithstanding the 
belief of Briggs (6) and Ireland (14) and their asso-
ciates that azathioprine is totally devoid of hepato-
toxicity. 
Because the definition of the cause for postopera-
tive hepatic malfunction is emerging as the most 
critical element in the care of liver recipients, other 
active diagnostic steps will need to be taken, of 
which repeated needle biopsies and cholangiog-
raphy are probably the most important. Even if 
unequivocal diagnosis of conditions like hepatitis, 
drug hepatotoxicity, rejection and intrahepatic in-
fection is not possible, repeated tissue study find-
ings could give a better insight into the evolution 
of recovery or failure of the transplants which will 
be applicable in future patients. Clearly, radical de-
cisions about therapy, sucll as one for retransplanta-
tion, should not be made without prior biopsies and 
without multiple efforts at trans hepatic cholangiog-
raphy to rule out large duct obstruction. 
The greatest dividend from improved diagnosis 
may be the better management of the biliary duct 
complications that have so beset liver transplanta-
tion in our hands (17, 26, 31) and as reported by 
Williams and his associates (35) in the King's 
College-Cambridge series in England. Bile fistulas 
usually require wide drainage. \Vith duct obstruc-
tion, reoperation is mandatory before there is 
incurable infection of the homograft. 
In our series of obstructions, the most common 
reoperation has been conversion from cholecysto-
jejunostomy to choledochojejunostomy (Fig. 3B 
and C). In the series herein reported, there were 
about 20 livers in which the ducts were certainly, 
or probably, obstructed. Only a few were success-
fully corrected, virtually all within our recent 
experience, including five of the 16 patients who 
are still alive. 
With such a high incidence of biliary tract com-
plications, continuous reassessment of the initial 
choice of reconstructive procedure will be neces-
sary. Although our usual first choice is a Roux-
en-Y cholecystojejunostomy, choledochocholedo-
TABLE VI.-PRINCIPAL REASONS FOR 35 ORTHO-
TOPIC HOMOGRAFTS BEING LOST AFTER TRANS-
PLANTATION INTO 33 ADULTS WHO EVENTUALLY 
DIED 
Time to death 
No. oj or grajt loss, 
Category examples days aT No. 
Acute technical. 11 
Graft 
necrotic (3) .. 7,8,8 6, 75, 85 
Iatrogenic duct 
obstruction 
(3)* ........ 10, 39,20 22, 25, 79 
Biliary 
fistula (5)* .. 23, 13,27,29, 34 5, 28, 63, 69, 70 
Acute neurologic. 6 
6, 3, 26, 32, 41, 22 4, 32, 39, 40, 61, 72 
Systemic 
infection§ ..... 7 
22,7, 35, 22, 11, 2, 3, 17, 54b, 62b, 
15, 9 81, 83 
Delayed biliary 
obstruction .... 6t 
564,408,62,111, 54a, 58, 60, 62a, 
62,47 87, 88 
Acute rejection. 1:1: 9 51 
Chronic 
rejection ...... 
° Recurrent tumor. 2 
349, 87 15,45 
Recurrent 
hepatitis ...... 623 36 
No satisfactory 
explanation ... 161 66 
a, Primary graft in patient who underwent retransplantation; b, second 
graft. 
*Reoperation was attempted in three of these patients, onc with obstruc· 
tion and two with fistula. 
tAttempts were made to operate secondarily upon four of these patients. 
tFour other grafts contained residual changes or repair following acute 
rejection, but this was not considered to be the main cause of failure. 
§Bacterial or fungal or both. 
chostomy with aT-tube stent has been used 
frequently, taking pains to provide broad wound 
drainage. The former operation has had a high 
incidence of obstruction, and the latter has carried 
a high risk of fistula (26). With either complica-
tion, we (17) and Waldram and his group (34) 
have noted a remarkable tendency for the ducts to 
become filled with a chalk-like debris, leading to 
what has been called the inspissated bile syndrome. 
Periodic reassessment also will be necessary of the 
influence of the original host disease upon the out-
come insofar as this factor influences future patient 
selection. None of the diseases for which liver 
transplantation has been used so far can be cate-
gorically precluded as an indication for further 
trials, especially in children. The brightest chapter 
in liver transplantation has been in the treatment of 
inborn errors of metabolism in children, including 
our two patients with \Nilson's disease, our patient 
with alpha-i-antitrypsin deficiency and the child 
of Daloze (8) with Niemann-Pick disease. 
Although the experience with adults with cir-
rhosis in general and with alcoholic cirrhotics in 
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particular has been dismal, this has often been 
because of their appalling condition at the time of 
treatment. Earlier decisions need to be made about 
treatment with transplantation. Even continued 
efforts to trcat recipients with chronic HB,Ag 
antigenemia are probably warranted, especially if 
hyperimmune specific gamma globulin therapy can 
be offered. 
The treatment of hepatic malignant tumors with 
liver replacement remains a controversial issue. 
One of our patients is cured of a hepatoma after 
almost six years, but that neoplasm was small and 
was an incidental finding in a liver that had biliary 
atresia. Fi\t' other patients with hepatomas who 
lived long enough for observations to bc made had 
recurrences as did a sixth patient whose native liver 
and, latcr, whose liner graft were destroyed by a 
hemangioendothelial sarcoma. Tvv'o of our three 
patients with intrahepatic duct cell carcinomas are 
aliye one and one-quarter and one and three-
quarter years postoperatively. Unfortunately, the 
patient with the long survival period has massive 
recurrences which are predominantly in the 
homograft. 
Although details have varied, the over-all mes-
sage from 'Villiams and his associate;; (35) has been 
the same, although somewhat more optimistically 
expressed. In their series of transplantations for four 
hepatomas, five duct cell carcinomas, two meta-
static malignant lesions and one cholangiocarci-
noma, eight of the 12 patients were afflicted with 
recurren t neoplasm. In four of their five pa ticn ts 
with duct cell carcinoma, obvious metastases de-
veloped, the exception being a recipient who died 
after three weeks. On the other hand, hepatoma 
recurred once in four instances, but only one of 
these recipients lived for as long as a year. That 
exceptional patient who died of biliary obstruction 
after more than five years was free of metastases at 
autopsy. However, the original tumor was ap-
parently slow growing, since she had been aware 
of an abdominal mass for more than six years 
preceding transplantation. 
Recurrenees after liver transplantation for pri-
mary hepatic malignant tumors also have been 
recorded by Hume (12) and Fortner (10) and their 
associates. It is axiomatic that the outcome in any 
given patient will depend on the extent of the 
neoplasm at the time of transplantation. In this 
connection, a precautionary note about what 
constitutes genuine candidacy for liver replacement 
may be introduced on the basis of our unusually 
large experience with hepatic trisegmentectomy, a 
partial liver resection in which approximately 85 
per cent of the liver is removed (24). A number of 
the patients in that series who, as it turned out, 
could be treated by conventional means had been 
referred to us for eonsideration of liver transplanta-
tion after an erroneous decision of nonrescclability 
had been made at earlier operations. The same 
point has been made by Smith (23). 
SUMMARY 
During the 11 Yz year period ending 13 months 
ago, 93 consecutive patients were treated with 
orthotopic liver transplantation. Fifty-six of the 
recipients were 18 years old or younger, and the 
other 37 were adults. The most common indica-
tions for operation were biliary atresia, primary 
hepatic malignant tumor, chronic aggressive hepa-
titis and alcoholic cirrhosis. 
There has been a gradual improvement in re-
sults throughout the period of study, although not 
to a satisfactory level. Twenty-seven of the 93 pa-
tients survived for at least one year after liver re-
placement with a maximum of six years, and 16 are 
still alive after 13 to 71 months. The 11 late deaths 
after one to six years were caused by chronic rejec-
tion, biliary obstruction, recurrence of hepatoma, 
systemic infection or hepatitis of the homograft. 
Rejection of the liver as judged by classical 
histopathologic criteria played a surprisingly small 
role in the heavy over-all mortality, accounting for 
less than 10 per cent of the deaths. Technical or 
mechanical problems, especially those of biliary 
duct reconstruction, were a far greater cause of 
failure, as were systemic infections. Six of the 37 
adult recipients had lethal cerebrovascular acci-
dents during, or just after, operation. When ab-
normalities of liver function dc\'eloped in the post-
operative period, the nearly automatic diagnosis 
of homograft rejection, in retrospect, proved to 
have been wrong in most instances. 
Further development of liver transplantation 
depends upon two kinds of progress. There must 
be reduction of operative and early postoperative 
accidents and complications by more discrimi-
nating patient selection, purely technical improve-
ment and bettcr standardization of billary duct 
reconstruction. The second area will be in sharpen-
ing the criteria for the differential diagnosis of 
postoperative hepatic malfunction, including the 
liberal use of transhcpatic cholangiography and 
needle biopsy. Only then can better decisions be 
made about changes in medication or about the 
need for secondary corrective surgical procedures. 
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